Important CRC signaling components of the Wnt pathway, catenin and Tcf-4 levels, were considerably reduced in CRC rats treated with AIAgNPs and AIAuNPs compared with paclitaxel. This evidence concerns the gene TCF4 and colorectal carcinoma.